StockClub

ENTA

ENTAEnanta Pharmaceuticals, Inc.$ --
Enanta Pharmaceuticals, Inc.

Enanta Pharmaceuticals, Inc.

ENTA

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2026 Q1
Revenue
19M USD
YoY +9.8%
Operating Income
-11M USD
YoY +52.2%
Net Income
-12M USD
YoY +46.4%
EPS
-0.56$
YoY +46.7%

Revenue

$18.6M
FY2024 Q2$35.1M
$35.1M
Q2
FY2024 Q3$53M
$53M
Q3
FY2024 Q4$67.6M
$67.6M
Q4
FY2025 Q1$17M
$17M
Q1
FY2025 Q2$31.9M
$31.9M
Q2
FY2025 Q3$50.2M
$50.2M
Q3
FY2025 Q4$65.3M
$65.3M
Q4
FY2026 Q1$18.6M
$18.6M
Q1
Actual
+$1.7M (+9.8%)

Net Income

$-11.9M
FY2024 Q2$-64.6M
$-64.6M
Q2
FY2024 Q3$-87.2M
$-87.2M
Q3
FY2024 Q4$-116M
$-116M
Q4
FY2025 Q1$-22.3M
$-22.3M
Q1
FY2025 Q2$-44.9M
$-44.9M
Q2
FY2025 Q3$-63.2M
$-63.2M
Q3
FY2025 Q4$-81.9M
$-81.9M
Q4
FY2026 Q1$-11.9M
$-11.9M
Q1
Actual
+$10.4M (+46.4%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$122.5M
Est:$124.4M
FY2020MISS
$122.5M
FY2021MISS
Actual:$97.1M
Est:$99.9M
FY2021MISS
$97.1M
FY2022MISS
Actual:$86.2M
Est:$89M
FY2022MISS
$86.2M
FY2023BEAT
Actual:$79.2M
Est:$72.9M
FY2023BEAT
$79.2M
FY2024MISS
Actual:$67.6M
Est:$71.2M
FY2024MISS
$67.6M
FY2025MISS
Actual:$65.3M
Est:$66.2M
FY2025MISS
$65.3M

Analyst Estimates